News
The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting ...
Major depressive disorder affects hundreds of millions worldwide, but a key to understanding its origins may lie in the brain ...
Since the COVID-19 pandemic, levels of clinically elevated depression and anxiety symptoms in children have skyrocketed ...
A new meta-analysis suggests that people with major depressive disorder have lower levels of the brain antioxidant ...
Studies have linked excessive screen time to mental health problems like depression in adolescents. | Neuroscience ...
7d
PsyPost on MSNSome dark personality traits may help buffer against depression, new psychology research suggestsDark traits like narcissism and psychopathy are often associated with dysfunction, but new findings reveal that certain ...
A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to ...
New research shows a single dose leads to 'robust' reductions in depression and anxiety up to 2 years afterward.
Compass Pathways’ depression drug trial meets goals but falls short of investor hopes, triggering a sharp share selloff.
A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly ...
A new study from the American Cancer Society’s medical journal found that psilocybin — the active ingredient in “magic ...
The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results